Precautions must be taken to minimize staff exposure to biological agents

CMS has reopened it's decision on next-generation sequencing in patients with advanced cancers

Hospital outreach labs are now challenged to collect and report private payer pricing, but there may be an upside

The immediate and lingering effects on agencies and people

Proposal of a single regulatory pathway for kits and LDTs spurs controversy

How an automated workstation can create an audit-ready clinical lab

Better communication about privacy and confidentiality can help encourage potential biobank donors

Regulatory requirements aim to get the right results to the right patients